New research highlights the significant health care resource utilization burden of generalized pustular psoriasis (GPP), ...
Vanda and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise imsidolimab to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback